Ocugen, INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ
Janus Henderson Group Ltd. has disclosed a beneficial ownership of 3.0% in Ocugen, Inc., holding 10,000,000 shares and warrants.
NASDAQ
State Street Corporation has reported a beneficial ownership of 6.3% in Ocugen Inc. common stock as of June 30, 2026.
NASDAQ
Millennium Management LLC, along with affiliated entities and Israel A. Englander, has reported beneficial ownership of 5.2% of Ocugen, Inc.'s common stock.
NASDAQ
The Vanguard Group reported a 5.27% beneficial ownership stake in Ocugen Inc's common stock as of December 31, 2025, in a Schedule 13G filing.
NASDAQ
Janus Henderson Group plc has reported a 6.0% beneficial ownership stake in Ocugen, Inc., holding 20 million shares of common stock.
NASDAQ
The Vanguard Group has filed an amended Schedule 13G, reporting a 4.87% beneficial ownership stake in Ocugen Inc's common stock.
NASDAQ
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 1.9% of Ocugen, Inc.'s common stock as of June 30, 2025.
NASDAQ
State Street Corporation has filed a Schedule 13G, revealing a passive beneficial ownership of 2% in Ocugen Inc.'s common stock as of December 31, 2024.